Document is current
Any future updates will be listed below
-
Authors
Walsh, Jaclyn M. L. https://orcid.org/0000-0001-6292-1006
Miao, Vincent N.
Owings, Anna H. https://orcid.org/0000-0002-1139-8857
Tang, Ying https://orcid.org/0000-0003-4357-2343
Bromley, Joshua D.
Kazer, Samuel W.
Kimler, Kyle https://orcid.org/0000-0003-4735-9064
Asare, Chelsea
Ziegler, Carly G. K.
Ibrahim, Samira
Jivanjee, Tasneem
George, Micayla
Navia, Andrew W.
Drake, Riley S.
Parker, Adam
Billingsley, Benjamin C.
Dotherow, Paul
Tarugu, Spurthi
Kota, Sai K.
Laird, Hannah
Wichman, T. Grant
Davis, Yesenia T.
Dhaliwal, Neha S.
Pride, Yilianys
Guo, Yanglin
Senitko, Michal
Harvey, Jessie
Bates, John T. https://orcid.org/0000-0001-5545-6871
Diamond, Gill https://orcid.org/0000-0002-3596-9773
Garrett, Michael R.
Robinson, D. Ashley
Frame, I. J.
Lyons, Jonathan J. https://orcid.org/0000-0002-2346-8189
Robinson, Tanya O.
Shalek, Alex K.
Horwitz, Bruce H.
Glover, Sarah C.
Ordovas-Montanes, Jose https://orcid.org/0000-0001-5444-5601
-
Funding
Funding for this research was provided by:
Pew Charitable Trusts
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL162642)
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (DE031928)
Warren Alpert Foundation
- License Information
-
More Information
Article History
Received: 16 April 2024
Accepted: 5 December 2024
First Online: 20 January 2025
Competing interests
: V.N.M. reports compensation from MPM Capital and RA Capital Management unrelated to this work. S.W.K. reports compensation for consulting services with Monopteros Therapeutics, Flagship Pioneering and Radera Biosciences. M.S. reports compensation for consulting services with GE Precision Healthcare. J.J.L. reports compensation for consulting services with Blueprint Medicines and Human Immunology Biosciences. J.O.-M. reports compensation for consulting services with Cellarity, Tessel Biosciences and Radera Biotherapeutics. A.K.S. reports compensation for consulting and/or SAB membership from Merck, Honeycomb Biotechnologies, Cellarity, Hovione, Ochre Bio, Third Rock Ventures, Relation Therapeutics, Dahlia Biosciences, Bio-Rad Laboratories, IntrECate Biotherapeutics, FogPharma and Passkey Therapeutics. C.G.K.Z., V.N.M., A.H.O., A.W.N., Y.T., J.D.B., A.K.S., S.C.G., B.H.H. and J.O.-M. are co-inventors on a provisional patent application relating to methods of stratifying and treating viral infections. The other authors declare no competing interests.
